Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI) Grant

Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI) Grant

Status: ACTIVE
Funder: Pfizer, Inc.
Amount: Up to US $250,000
Last Updated: March 19, 2026

Summary

Overview

Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI) This RFP invites research proposals aimed at assessing clinical outcomes associated with the use of Aztreonam-Avibactam (ATM-AVI) in real world clinical settings. In scope are adult patients with suspected or documented infections due to aerobic gram negative organisms. Eg. CRE-MBL, Stenotrophomonas maltophilia, treated with ATM-AVI. Geographic Scope Countries where ATM-AVI is available (ex-US) and used in clinical practice at the time of RFP release, including but not limited to parts of EU, the United Kingdom, the Middle East, and selected Asia-Pacific markets. Proposals from institutions already participating in Pfizer-sponsored or funded, overlapping ATM-AVI RWE study may be considered out of scope. Proposals involving studies on patients that have received ATM-AVI via pre-approval or pre-launch expanded access routes may be considered out of scope Project Types and Area of Interest Potential applicants are requested to submit research proposals to study the below outcomes following treatment with ATM-AVI for adult patients with suspected or documented infections with aerobic gram negative organisms e.g. CRE-MBL, S. maltophilia. Clinical effectiveness with ATM-AVISafety outcomes with ATM-AVIMicrobiological outcomes with ATM-AVIHealth Economic outcomes with ATM-AVI (in addition to any of the above) Proposals may include data from special populations such as – immunocompromised (solid organ transplant or haemato-oncological patients) Funding Range and Project Length Individual projects requesting up to $50,000 USD will be considered. The total budget for this RFP is $ 250,000 USDMaximum project length is 12 months

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.